Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunological Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00418587
What this trial is testing

Vitamin D Therapy in Patients With Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Medical University of South Carolina 18
Not applicableLooking for participantsNCT06626893
What this trial is testing

Integrative "Omics" Approaches for Leukemia Target Identification and Matched Therapeutic Intervention

Who this might be right for
Myeloid Leukemia, AcuteLeukemia, Acute Lymphoblastic
Azienda Ospedaliero-Universitaria di Parma 100
Large-scale testing (Phase 3)Study completedNCT01360021
What this trial is testing

New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day

Who this might be right for
Asthma
AstraZeneca 214
Not applicableStudy completedNCT00099684
What this trial is testing

Safety, Effectiveness, and Tolerability of Ezetimibe Combined With Statins for the Treatment of High Cholesterol in HIV Infected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 44
Testing effectiveness (Phase 2)Study completedNCT04077684
What this trial is testing

Efficacy and Safety of Low-dose IL-2 in Patients With SLE: a Multicenter, Randomised, Placebo-controlled Trial

Who this might be right for
Systemic Lupus Erythematosus
Peking University People's Hospital 152
Not applicableUnknownNCT03046433
What this trial is testing

Children-Adult Asthma Cohort Study in China

Who this might be right for
Asthma in Children
Beijing Children's Hospital 4,000
Not applicableUnknownNCT04024033
What this trial is testing

Effects of Pine Cone Extract on Serum IgE Levels in Perennial Rhinitis

Who this might be right for
Perennial Allergic Rhinitis
University of South Florida 36
Testing effectiveness (Phase 2)Study completedNCT00002652
What this trial is testing

Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
University of Arkansas
Testing effectiveness (Phase 2)Study completedNCT01969747
What this trial is testing

Empagliflozin add-on to Insulin in Type 1 Diabetes Mellitus Over 28 Days

Who this might be right for
Diabetes Mellitus, Type 1
Boehringer Ingelheim 75
Not applicableStudy completedNCT00572338
What this trial is testing

Therapeutic Research in Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas 6,388
Not applicableUnknownNCT06516458
What this trial is testing

Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis Relapse+1 more
Shirley Ryan AbilityLab 40
Testing effectiveness (Phase 2)Looking for participantsNCT06716658
What this trial is testing

JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas

Who this might be right for
Lymphoma, T-CellNK-LGL LeukemiaT-LGL Leukemia+7 more
Institute of Hematology & Blood Diseases Hospital, China 48
Testing effectiveness (Phase 2)Study completedNCT04836858
What this trial is testing

Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis
Novartis Pharmaceuticals 71
Not applicableStudy completedNCT00142155
What this trial is testing

Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 300
Not applicableNot Yet RecruitingNCT07394478
What this trial is testing

Study of the Association Between Sacroiliitis/Axial Spondylarthritis and Giant Cell Arteritis/ Polymyalgia Rheumatica

Who this might be right for
Giant Cell Arteritis (GCA)SpondylarthritisPolymyalgia Rheumatica
Hôpital NOVO 10
Not applicableNot Yet RecruitingNCT07121985
What this trial is testing

Multispectral Optoacoustic Imaging for the Detection of Inflammation and Damage of Peripheral Nerves in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy

Who this might be right for
CIDP - Chronic Inflammatory Demyelinating PolyneuropathyGuillain-Barré Syndrome (GBS)
University of Erlangen-Nürnberg Medical School 30
Testing effectiveness (Phase 2)Study completedNCT00994643
What this trial is testing

Safety and Efficacy Study of Immunotherapy With Rituximab and Interleukin-2 in Patients With Non-Hodgkin's Lymphoma

Who this might be right for
High Risk Non-Hodgkin's Lymphoma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 11
Not applicableStudy completedNCT03416543
What this trial is testing

Effect of a New BI-specifiC Antibody Towards Dendritic Cells on Inflammation in Rheumatoid Arthritis

Who this might be right for
Rheumatoid ArthritisGoutOsteoarthritis
University Hospital, Tours 45
Not applicableStudy completedNCT07152015
What this trial is testing

Multiple Sclerosis, Sarcopenia and Respiration

Who this might be right for
Multiple Sclerosis
Uskudar University 40
Early research (Phase 1)Study completedNCT01149915
What this trial is testing

Study of Hypoxia-Activated Prodrug TH-302 to Treat Advanced Leukemias

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+3 more
Threshold Pharmaceuticals 40
Next Page